(Q40135212)

English

Identification of a novel NY-ESO-1 promiscuous helper epitope presented by multiple MHC class II molecules found frequently in the Japanese population

scientific article published on 4 May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Identification of a novel NY-ESO-1 promiscuous helper epitope presented by multiple MHC class II molecules found frequently in the Japanese population (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

author name string

Takayuki Ohkuri

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Masayoshi Sato

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Hiroyuki Abe

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Keiko Tsuji

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Yuka Yamagishi

5

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Hiroaki Ikeda

6

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Naoki Matsubara

7

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Hidemitsu Kitamura

8

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Takashi Nishimura

9

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

publication date

4 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

98

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1092-1098

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

The PTEN pathway in Tregs functions as a critical driver of the immunosuppressive tumor microenvironment and tolerance to apoptotic cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

mRNA expression of tumor-associated antigens in melanoma tissues and cell lines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

The critical role of type-1 innate and acquired immunity in tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

Antitumor effects of systemic and local immunization with a CTL-directed peptide in combination with a local injection of OK-432.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

Th1 cell adjuvant therapy combined with tumor vaccination: a novel strategy for promoting CTL responses while avoiding the accumulation of Tregs.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

Th1 and Th2 cell clones to a poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

In vitro stimulation of CD8 and CD4 T cells by dendritic cells loaded with a complex of cholesterol-bearing hydrophobized pullulan and NY-ESO-1 protein: Identification of a new HLA-DR15-binding CD4 T-cell epitope.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00501.X

21 January 2018

Identifiers

10.1111/J.1349-7006.2007.00501.X

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40135212&oldid=1886487630"